valerates has been researched along with Diabetes Mellitus, Adult-Onset in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; Cai, K; Chen, Q; Li, J; Luo, Q; Ma, Y; Zhang, J; Zhong, C | 1 |
| Almgren, P; Brunkwall, L; Ericson, U; Fernandez, C; Hellstrand, S; Melander, O; Nilsson, PM; Orho-Melander, M; Ottosson, F; Smith, E | 1 |
| Inoue, Y; Iwasaki, R; Kuhara, T; Matsumoto, I; Morimoto, S; Yu, WM | 1 |
| Chang, DM; Fuh, MM; Jeng, CY; Shian, LR | 1 |
| Chen, JJ; Chou, TY; Han, HK; Ho, LT; Li, SH; Liu, YF; Perng, JC | 1 |
5 other study(ies) available for valerates and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Gut microbial products valerate and caproate predict renal outcome among the patients with biopsy-confirmed diabetic nephropathy.
Topics: Biopsy; Caproates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Gastrointestinal Microbiome; Humans; Kidney; Kidney Failure, Chronic; Male; Prognosis; Valerates | 2022 |
Dimethylguanidino Valerate: A Lifestyle-Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Cause of Death; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Exercise; Female; Guanidines; Humans; Incidence; Life Style; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Risk Reduction Behavior; Sedentary Behavior; Sugar-Sweetened Beverages; Sweden; Valerates; Vegetables | 2019 |
Increased urinary excretion of beta-hydroxyisovaleric acid in ketotic and non-ketotic type II diabetes mellitus.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Female; Gas Chromatography-Mass Spectrometry; Glycosuria; Humans; Leucine; Male; Middle Aged; Trimethylsilyl Compounds; Valerates | 1990 |
The hypolipidemic effect of gemfibrozil on hyperlipidemia in patients with non-insulin-dependent diabetes mellitus.
Topics: Aged; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pentanoic Acids; Valerates | 1986 |
Gemfibrozil has antilipemic effects on diabetic patients with hyperlipidemia.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Valerates | 1987 |